Evidence map›Paper›PMID 17158148›Full record

ArticleNucleic acids research2007

Human RAD18 is involved in S phase-specific single-strand break repair without PCNA monoubiquitination.

Naoko Shiomi, Masahiko Mori, Hideo Tsuji, Takashi Imai, Hirokazu Inoue, Satoshi Tateishi, Masaru Yamaizumi, Tadahiro Shiomi

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Impacts of arsenic on Rad18 and translesion synthesis.Toxicology and applied pharmacology · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Naoko ShiomiRadgenomics Research Group, Research Center for Charged Particle Therapy, Chiba 263-8555, Japan.
Masahiko Mori
Hideo Tsuji
Takashi Imai
Hirokazu Inoue
Satoshi Tateishi
Masaru Yamaizumi
Tadahiro Shiomi
Kumamoto University · JPRadiation Effects Research Foundation · JPSaitama University · JPTransgenomic (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Switching from a replicative to a translesion polymerase is an important step to further continue on replication at the site of DNA lesion. Recently, RAD18 (a ubiquitin ligase) was shown to monoubiquitinate proliferating cell nuclear antigen (PCNA) in cooperation with RAD6 (a ubiquitin-conjugating enzyme) at the replication-stalled sites, causing the polymerase switch. Analyzing RAD18-knockout (RAD18-/-) cells generated from human HCT116 cells, in addition to the polymerase switch, we found a new function of RAD18 for S phase-specific DNA single-strand break repair (SSBR). Unlike the case with polymerase switching, PCNA monoubiquitination was not necessary for the SSBR. When compared with wild-type HCT116 cells, RAD18-/- cells, defective in the repair of X-ray-induced chromosomal aberrations, were significantly hypersensitive to X-ray-irradiation and also to the topoisomerase I inhibitor camptothecin (CPT) capable of inducing single-strand breaks but were not so sensitive to the topoisomerase II inhibitor etoposide capable of inducing double-strand breaks. However, such hypersensitivity to CPT observed with RAD18-/- cells was limited to only the S phase due to the absence of the RAD18 S phase-specific function. Furthermore, the defective SSBR observed in S phase of RAD18-/- cells was also demonstrated by alkaline comet assay.

Indexed as

DNA Breaks, Single-StrandedDNA RepairS PhaseCamptothecinCell Line, TumorChromosome AberrationsComet AssayDNA-Binding ProteinsDNA DamageEnzyme InhibitorsGene DeletionGenes, LethalGene TargetingHumansProliferating Cell Nuclear AntigenTopoisomerase I InhibitorsCamptothecinDNA-Binding ProteinsEnzyme InhibitorsProliferating Cell Nuclear AntigenRAD18 protein, humanTopoisomerase I InhibitorsUbiquitinUbiquitin-Protein LigasesXRCC4 protein, human

Identifiers

PMID17158148
PMCPMC1802632
OpenAlexW2046732630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.